Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

ro-intestinal, human genetic therapies and renal.

The Company is a public limited company incorporated under the Companies Act 1985 and domiciled in the United Kingdom. The address of its registered office is Hampshire International Business Park, Chineham, Basingstoke, Hampshire, United Kingdom, RG24 8EP.

The Company has its primary listing on the London Stock Exchange and its secondary listing on the NASDAQ National Market in the United States of America.

These consolidated financial statements are presented in US Dollars as this is the currency of the primary economic environment in which the Group operates.

2. Accounting Presentation and Policies

While the financial information included in this preliminary announcement has been prepared in accordance with the recognition and measurement criteria of IFRS, this announcement does not itself contain sufficient disclosure and other information to fully comply with IFRS. The Company's statutory accounts for the year ended December 31, 2007 have been prepared in accordance with IFRS as adopted by the EU. The accounting policies adopted in this preliminary announcement are consistent with those followed in the preparation of the Company's statutory accounts for the years ended December 31, 2007 and 2006. Certain amounts reported in previous periods in respect of manufacturing set up costs for new products have been reclassified from research and development to cost of sales to conform to the 2007 presentation.

The financial information set out above does not constitute the Company's statutory accounts for the years ended December 31, 2007 or 2006, but is derived from those accounts. Statutory accounts for 2006 have been delivered to the Registrar of Companies and those for 2007 will be delivered in due course. The auditors have reported on those accounts; their reports were unqualified and did not contain statements under s. 237(2) or (3) Companies Act 1985.

3. Business c
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... Asymmetrex, LLC founder ... evaluating the full range of capabilities of its unique cache of technologies for ... the day-to-day renewal and repair of normal tissues and organs. This property makes ...
(Date:7/28/2015)... ... ... 530 sample changer for vials can be used with Anton Paar density meters, viscometers ... mPas (internal air) up to 36,000 (external air) – and can process up to 71 ... is its removable magazine, which is easily lifted off its hub and carried by hand ...
(Date:7/28/2015)... ... 28, 2015 , ... In terms of value, aluminium hydroxide ... volume reached close to 1.84 million tonnes in the same year. As of ... the region’s total aluminium hydroxide production; the country’s aluminium hydroxide production posted a ...
(Date:7/28/2015)... Deerfield Management Company, L.P. today announced the ... will invest in groundbreaking advancements in science that may ... orphan diseases. The venture capital fund will also back ... and improve the way healthcare is delivered to patients. ... venture funds in the sector, will donate all profits ...
Breaking Biology Technology:Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 2Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 3Asymmetrex Plans to Report Results From Adult Stem Cell Technology Development Milestone Studies At End of Summer 4New Moves in Automatic Sample Handling: Introducing Xsample 530 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 2EU27 Aluminium Hydroxide Market Analysed and Forecast by BAC Reports in New Research Study Available at MarketPublishers.com 3Deerfield Launches $550 Million Healthcare Venture-Capital Fund 2Deerfield Launches $550 Million Healthcare Venture-Capital Fund 3
... Value Chain, a market leader in business transformation consulting, ... Life Sciences and Health Care Practice Group. In his ... clients in the Health Care and Life Science industry ... development, and service offerings concentrating on alignment of organizational ...
... CITY, Nov. 2, 2011 Myriad Genetics, Inc. (NASDAQ: ... the 2011 "Corporate Spirit of Giving Award" by the Utah ... company that has made outstanding philanthropic and charitable service contributions ... the Utah Philanthropy Day luncheon at the Little America Hotel ...
... identified a potential drug therapy for a premature ageing disease ... times as fast as the usual rate. The study ... DNA damage defects in cells and could provide a model ... The findings could have significant benefits, such as reducing degeneration ...
Cached Biology Technology:Axia Value Chain Appoints John Christina Managing Director of Life Sciences Practice 2Myriad Genetics Receives the "Corporate Spirit of Giving Award" From the Utah Philanthropy Day Committee 2Myriad Genetics Receives the "Corporate Spirit of Giving Award" From the Utah Philanthropy Day Committee 3Cellular repair could reduce premature aging 2Cellular repair could reduce premature aging 3
(Date:7/21/2015)... NEW YORK , July 21, 2015 /PRNewswire/ ... critical systems, as seen in the recent U.S. ... enterprises a solution to the infosec conundrum, but ... data is stored. To address this dilemma, Biometrics-as-a-Service ... of its Biometric Tokenization SDK for third party ...
(Date:7/9/2015)... July 07, 2015 ... addition of the "Biometrics for Banking; Market ... report to their offering. The ... to this growth and the forecast is that ... revenue for companies involved in delivering biometric systems ...
(Date:7/8/2015)... 8, 2015  Trovagene, Inc. (NASDAQ: TROV ... announced the launch of a study that aims ... Monitoring℠ (PCM) technology for predicting response to treatment ... combination of the novel immunotherapy agents Yervoy® (ipilumumab), ... inhibitor. The 50-patient study will be led by ...
Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
... to be Featured in the Biggest Government IT Security Event in ... ... Group, Ltd (OTC,Bulletin Board: TTNUF), a leading biometric and security solutions provider,announced ... of the key vendors to showcase their products and technologies in the,Biometric ...
... team of researchers, led by the University of Sheffield, ... climate extremes. The new research could help in determining ... With fishing pressures high and stock size low, there ... cod and other fisheries. The new findings, published in ...
... Using an innovative device with microscopic chambers, researchers ... important new information about how bacteria survive in ... These biofilms play key roles in cystic fibrosis, ... researchers say their findings could help in the ...
Cached Biology News:Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 2Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 3Titanium Group to Showcase Products and Technologies in Prestigious Government Seminar 4Ice age imprint found on cod DNA 2Together we stand: bacteria organize to survive hostile zones 2Together we stand: bacteria organize to survive hostile zones 3